logo
Monarch Butterflies Are Losing Their Navigational Abilities. You Can Guess Why

Monarch Butterflies Are Losing Their Navigational Abilities. You Can Guess Why

Gizmodo18 hours ago
Each fall, millions of eastern North American monarch butterflies migrate up to 3,000 miles south to the mountains of central Mexico, then return to their northern range in the spring. These winged insects rely on a complex navigation system to go to and from their overwintering sites, and new research suggests climate change may be messing with it.
Monarch butterflies have two distinct biological 'compasses.' The primary one infers direction based on their circadian rhythm and the position of the Sun, but on overcast days, they switch to a backup compass that infers direction from Earth's magnetic field. Scientists already knew seasonal temperatures play a critical role in calibrating these navigational biomechanisms during the fall migration, but they weren't sure if the same rules apply to the spring migration. A new study published Wednesday, August 13, in the journal PLOS One confirmed that they do, suggesting that rising winter temperatures in Mexico could prevent monarchs from returning to their northern range.
'The question was, if they use the Sun compass or the magnetic compass to go southwards, do they use the same kind of compass mechanisms to fly back north? And we weren't sure what triggered that,' co-author Patrick Guerra, an independent neuroecology researcher based in North Carolina, told Gizmodo. He participated in this research while working as an assistant professor at the University of Cincinnati.
When temperatures drop in the fall, this shift calibrates both of the butterflies' biological compasses to point south, guiding them toward their overwintering sites in Mexico. 'Once they get there, they're basically overwintering in a fridge,' Guerra explained. His previous research showed that this long period of exposure to cool temperatures recalibrates the Sun compass to point north so that it can guide monarchs back to their summer range in the spring. In this new study, he and his colleagues investigated whether this is also true for the magnetic compass.
To that end, the researchers conducted a series of righting response trials with migratory and non-migratory monarchs. During these trials, the butterflies were exposed to artificial magnetic fields that mimic geographic conditions south of their overwintering sites, then positioned so they were upside down. Upon righting themselves, non-migrating monarchs faced magnetic north, whereas migrating monarchs faced magnetic south. This indicated that monarchs exhibit something akin to migratory restlessness—a compulsion to go toward the direction their migratory instincts are telling them to follow even if they can't actually fly there.
With this established, Guerra and his colleagues chilled the monarchs to trick their bodies into thinking they had gone through an overwintering period. When they performed the righting response trials again, the migrating monarchs pointed toward magnetic north. The non-migrating monarchs, however, still pointed toward magnetic south.
'That told us that, just like the Sun compass, the magnetic compass is recalibrated by the cold conditions that are consistent with being in Mexico while they're overwintering,' Guerra explained. 'So that kind of hammers home that their whole ability to navigate is really tuned to the environmental conditions that they're experiencing.'
Greenhouse gas emissions are increasing average temperatures around the world, including in the overwintering range of monarch butterflies. Guerra and his colleagues already knew that this threatened their primary navigation mechanism, but their new study indicates that their backup mechanism is at risk too. If temperatures get too warm, monarchs may lose the ability to return to their northern range in the spring. Determining the minimum temperature monarchs need to recalibrate their biological compasses for spring migration will require further research, but these findings underscore the threat that climate change poses to this species.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Alien worlds may not necessarily need water, scientists find: ‘We just opened a Pandora's box'
Alien worlds may not necessarily need water, scientists find: ‘We just opened a Pandora's box'

Yahoo

time6 minutes ago

  • Yahoo

Alien worlds may not necessarily need water, scientists find: ‘We just opened a Pandora's box'

Water may not be essential to support life, and an entirely different type of liquid could do the same in alien worlds, a new study claims. Until now, water has been considered a requirement for life on other worlds, with scientists defining the habitability of other planets based on its presence. However, a new lab experiment suggests salts existing in liquid form at lower temperatures in other worlds may host life, though unlike anything resembling Earth's water-based beings. Such liquid-salts, called ionic liquids, can exist below about 100 degrees Celsius and remain stable enough in the fluid state at wider conditions to be a hospitable environment for life-signature molecules like proteins, say researchers from the Massachussets Institute of Technology. The study, published in the journal PNAS, theorises that even planets that are too warm, or those with atmospheres at pressures too low to host liquid water, could still support pockets of ionic liquid. 'We consider water to be required for life because that is what's needed for Earth life. But if we look at a more general definition, we see that what we need is a liquid in which metabolism for life can take place,' says Rachana Agrawal, an author of the study from MIT. 'Now if we include ionic liquid as a possibility, this can dramatically increase the habitability zone for all rocky worlds,' Dr Agrawal said. On Earth, such ionic liquids are mainly only made for industries, and do not occur naturally – except for one natural case. One liquid salt is generated from the mixing of venoms produced by two rival species of ants. In the new study, scientists sought to understand the broad conditions under which ionic liquids can be naturally produced, including the range of temperatures and pressures. They started by mixing sulphuric acid with 30 different nitrogen-containing organic compounds across several temperatures and pressures. Researchers then observed whether an ionic liquid formed when they evaporated away the sulphuric acid in various vials. This work was based on previous work suggesting that some of these chemicals, considered ingredients associated with life, are surprisingly stable in sulphuric acid. Scientists also mixed the ingredients onto basalt rocks, which are known to exist on the surface of many rocky planets. 'We were just astonished that the ionic liquid forms under so many different conditions,' says Sara Seager, another author of the study. 'If you put the sulphuric acid and the organic on a rock, the excess sulphuric acid seeps into the rock pores, but you're still left with a drop of ionic liquid on the rock. Whatever we tried, ionic liquid still formed,' Dr Seager says. Researchers found that their reactions produced ionic liquid at temperatures up to 180 degrees Celsius and at extremely low pressures – much lower than that of the Earth's atmosphere. The findings suggest ionic liquids can naturally form on other planets where liquid water cannot exist, under the right conditions. 'We're envisioning a planet warmer than Earth, that doesn't have water, and at some point in its past or currently, it has to have had sulphuric acid, formed from volcanic outgassing,' Dr Seager says. 'This sulphuric acid has to flow over a little pocket of organics. And organic deposits are extremely common in the solar system,' she explained. Scientists hope to conduct further studies to see what life-signature molecules might survive and thrive in ionic liquids. 'We just opened up a Pandora's box of new research. It's been a real journey,' Dr Seager said.

Graft Failure Risk Rises in Paediatric Kidney Retransplants
Graft Failure Risk Rises in Paediatric Kidney Retransplants

Medscape

time7 minutes ago

  • Medscape

Graft Failure Risk Rises in Paediatric Kidney Retransplants

TOPLINE: In paediatric kidney transplant recipients, the risk for graft failure increased with each subsequent transplantation. After the second transplant, older donor age, transplantation from a deceased donor, shorter survival of the primary graft in non-sensitised recipients, higher panel-reactive antibody (PRA) levels, and an increasing number of human leucocyte antigen DR (HLA-DR) mismatches predicted a higher risk for graft failure. METHODOLOGY: Researchers analysed data from a European registry to determine the incidence and risk factors for graft failure and death after repeat kidney transplantation in paediatric recipients across Eurotransplant countries. They included 4527 primary paediatric kidney transplant recipients (median age, 11 years; 41% girls), of whom 1155 underwent a second, 259 a third, and 41 a fourth kidney transplantation. The median follow-up duration for the first, second, third, and fourth kidney transplantation was 8.83, 6.67, 5.75, and 5.58 years, respectively. The probability of graft failure (the need for dialysis or retransplantation) and death with a functioning graft was analysed in kidney transplantation recipients. Patient data collection included recipient sex and age; country; transplantation dates; PRA levels; primary kidney disease; graft failure dates; donor source, age, and sex; and the number of HLA mismatches. TAKEAWAY: The risk for graft failure increased with each subsequent kidney transplant, with 5-year rates of 15% after the first, 24% after the second, 30% after the third, and 40% after the fourth transplant. The risk for graft failure or death with a functioning graft was the highest in the first month after primary kidney transplantation and increased even further after each subsequent transplantation. After the second transplant, transplantation from deceased donors, older donor and recipient age, shorter survival of the first graft in non-sensitised recipients, higher PRA levels (1%-100%), and an increasing number of HLA-DR mismatches were associated with an increased probability of graft failure and death with a functioning graft. Transplants performed in more recent years were also associated with better survival outcomes. IN PRACTICE: "Each subsequent kidney transplantation in pediatric recipients carried a higher risk of GF [graft failure], particularly in the first months post-transplant. After the second transplantation, older calendar year of KTx [kidney transplantation], deceased donor (DD), older donor and recipient age, and increasing HLA-DR mismatches were associated with a higher predicted GF and death with functioning graft," the authors wrote. "In DD kidney allocation schemes, 2 HLA-DR mismatches should be avoided," they added. SOURCE: This study was led by Ferran Coens, Ghent University Hospital, Ghent, Belgium. It was published online on August 07, 2025, in Pediatric Nephrology. LIMITATIONS: This study had substantial missing data for HLA mismatches in living donor transplants, limiting the analysis of HLA mismatches to deceased donor kidney transplant recipients alone. Additionally, the analysis did not adjust for certain relevant peri- and post-transplant predictors of graft failure, such as cold and warm ischaemia time, socioeconomic status, and allograft rejection. DISCLOSURES: The registry involved in this study received funding through a grant from the Dietmar Hopp Stiftung, the European Society for Paediatric Nephrology, the German Society for Pediatric Nephrology, and other sources. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Drug Combinations for CVDs Tied to Bullous Pemphigoid Risk
Drug Combinations for CVDs Tied to Bullous Pemphigoid Risk

Medscape

time7 minutes ago

  • Medscape

Drug Combinations for CVDs Tied to Bullous Pemphigoid Risk

TOPLINE: A case-control study revealed that combinations of drugs for cardiovascular diseases and hypertension were frequently prescribed before a diagnosis of bullous pemphigoid (BP), but the risk associated with combinations did not exceed that associated with individual agents. The most common drug combinations included angiotensin-converting enzyme (ACE) inhibitors with statins and antiplatelets with statins. METHODOLOGY: Researchers conducted a nested case-control study using healthcare records from the Clinical Practice Research Datalink between 1998 and 2021 and analysed 16,844 BP cases and 79,493 age- and sex-matched control individuals having no BP diagnosis at the index date (the first date a BP diagnosis code was recorded). Association rule mining (ARM) identified the 10 most common drug class or active substance pairs prescribed to cases or control individuals on the same day and within 6 months before the index date. In the sensitivity analysis, researchers identified medication pairs prescribed within 30 days of each other and during the 6 months preceding the index date. Researchers quantified how often two drugs are co-prescribed compared with their independent prescribing by calculating a lift. They then derived the fold change (FC) as the ratio of a lift in cases vs control individuals. The analysis included multivariable conditional logistic regression to estimate the risk for BP following drug combinations and their constituent drugs. TAKEAWAY: The most frequent drug combinations associated with an increased risk for BP were ACE inhibitors-statins (FC of the lifts in the main analysis vs sensitivity analysis: 1.31 vs 1.18), antiplatelets-statins (1.23 vs 1.11), proton pump inhibitors (PPI)-antiplatelets (1.22 vs 1.14), PPI-statins (1.22 vs 1.14), and ACE inhibitors-antiplatelets (1.20 vs 1.09). For drug substances, combinations with a greater lift in BP cases were simvastatin-ramipril (FC, 1.30), simvastatin-aspirin (FC, 1.21), and ramipril-aspirin (FC, 1.19). After adjusting for BP-associated drugs, the Charlson Comorbidity Index, and relevant confounders, the increased risk remained significant for these drug class combinations: antiplatelets-statins (odds ratio [OR], 1.20), ACE inhibitors-statins (OR, 1.16), PPI-statins (OR, 1.22), ACE inhibitors-antiplatelets (OR, 1.26), and PPI-antiplatelets (OR, 1.43; P < .001 for all). The risk for BP associated with these frequently prescribed drug combinations was lower than the risk linked to each constituent drug at both class and substance levels. In both main and sensitivity analyses, patients who developed BP were more likely than control individuals to have received combinations of cardiovascular or antihypertensive drugs before diagnosis. IN PRACTICE: "The ARM algorithm exploratory analysis identified the most commonly prescribed drug combinations prior to BP. Logistic regression confirmed drug combinations for CVDs [cardiovascular diseases] or hypertension associated with increased BP risk," the authors wrote. "The increased BP risk following reported combinations was modest and was not greater than their constituent drugs. Given that the number of patients with BP is low, we do not suggest avoiding the reported drugs but instead being on the lookout for any skin reactions following treatments for CVDs or hypertension," they concluded. SOURCE: This study was led by Mikolaj Swiderski, University of Nottingham, Nottingham, England. It was published online on August 06, 2025, in Clinical and Experimental Dermatology. LIMITATIONS: The ARM algorithm considered only the frequency of prescriptions to obtain drug combinations. Additionally, the algorithm demonstrated limited clinical value, linking only half of the inferred drug class combinations with BP and failing to capture the sequence or precise timing of prescriptions. It also lacked dosage and treatment duration data, and as an exploratory tool, ARM could not establish causal relationships between drug exposures and the risk for BP. DISCLOSURES: This research was supported by the National Institute for Health and Care Research grant via the Research for Patient Benefit Programme. Swiderski reported receiving salary funding from this grant. Another author reported receiving salary funding from King's College London, University of Nottingham, and the National Institute for Health and Care Research East Midlands scholarship scheme. Additional disclosures are noted in the original article. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store